GB1462298A - Antibody productive hb ag vaccine and process for its preparation - Google Patents

Antibody productive hb ag vaccine and process for its preparation

Info

Publication number
GB1462298A
GB1462298A GB3604674A GB3604674A GB1462298A GB 1462298 A GB1462298 A GB 1462298A GB 3604674 A GB3604674 A GB 3604674A GB 3604674 A GB3604674 A GB 3604674A GB 1462298 A GB1462298 A GB 1462298A
Authority
GB
United Kingdom
Prior art keywords
vaccine
preparation
protein
antibody formation
productive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3604674A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GC Biopharma Corp
Original Assignee
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Korea filed Critical Green Cross Corp Korea
Publication of GB1462298A publication Critical patent/GB1462298A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
GB3604674A 1974-01-28 1974-08-15 Antibody productive hb ag vaccine and process for its preparation Expired GB1462298A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1161774A JPS5523254B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-01-28 1974-01-28

Publications (1)

Publication Number Publication Date
GB1462298A true GB1462298A (en) 1977-01-19

Family

ID=11782869

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3604674A Expired GB1462298A (en) 1974-01-28 1974-08-15 Antibody productive hb ag vaccine and process for its preparation

Country Status (6)

Country Link
JP (1) JPS5523254B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1023662A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH617350A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2440926C3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2258864B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1462298A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU599007B2 (en) * 1984-10-02 1990-07-12 New York Blood Center, Inc., The Hepatitis B antigenic compositions and vaccines against hepatitis B derived therefrom

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017360A (en) * 1975-05-14 1977-04-12 Merck & Co., Inc. Method for purifying hepatitis B antigen
GB1571829A (en) 1976-04-06 1980-07-23 Lafon Labor Sulphur-containing diaryl compounds and oxygen-containing diaryl compounds
JPS591981B2 (ja) * 1976-08-27 1984-01-14 株式会社ミドリ十字 ＨＢｓ抗体検出用受身赤血球凝集試験用担体の製造方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU599007B2 (en) * 1984-10-02 1990-07-12 New York Blood Center, Inc., The Hepatitis B antigenic compositions and vaccines against hepatitis B derived therefrom

Also Published As

Publication number Publication date
DE2440926A1 (de) 1975-07-31
JPS50105817A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-08-20
DE2440926C3 (de) 1978-11-30
JPS5523254B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1980-06-21
CH617350A5 (en) 1980-05-30
FR2258864A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-08-22
FR2258864B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-06-30
CA1023662A (en) 1978-01-03
DE2440926B2 (de) 1978-04-06

Similar Documents

Publication Publication Date Title
NL930015I2 (nl) Werkwijze ter bereiding van nonapepide-aminederivaten, en farmaceutische preparaten met ovulatie-opwekkende werking daaruit.
SE9102975L (sv) Bakterofag och vaerd till anvaendning foer framstaellning av hiv-proteiner och peptider
ES8900006A1 (es) Un procedimiento para preparar un complejo de inmunogeno
ES487106A0 (es) Un metodo para producir al menos un polipeptido que muestra antigenicidad de hbv
NL178594C (nl) Werkwijze ter bereiding van geneesmiddelen met antihypertensieve werking, alsmede werkwijze ter bereiding van 2-(gesubstitueerd amino)4-amino 6,7,8-trimethoxychinazolinen, geschikt voor gebruik bij eerstgenoemde werkwijze.
JPS5461112A (en) Oncostatic polysaccharide* its preparation* and oncostatic drugs containing it as an effective component
ATE248863T1 (de) Cyclodextrinderivate und verfahren zu deren herstellung
GB1524431A (en) Production of long acting insulin preparations
DK614987D0 (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
DE2962569D1 (en) Immune serum globulin preparations and method to produce them
DE3689622D1 (de) Impfstoffe gegen menschliche respiratorische viren.
IE781880L (en) Immunogenic herpes virus subunit
GB1462298A (en) Antibody productive hb ag vaccine and process for its preparation
NL7500224A (nl) Werkwijze voor het bereiden van prostaglandine- oga; werkwijze ter bereiding van farmaceu- e preparaten, alsmede de door toepassing an vervaardigde voorwerpen.
GB984074A (en) Antigen products and production thereof
SE7704245L (sv) Medel for profylax och terapi av gastroenterit
GB928807A (en) Combined poliomyelitis-diphtheria-tetanus-pertussis antigen and methods for its manufacture
SE7508857L (sv) Forfarande for framstellning av 19,20-bis-norprostansyror.
NL7603767A (nl) Werkwijze voor de bereiding van nieuwe farmaceu- tische preparaten, alsmede preparaten verkregen volgens deze werkwijze.
NL7503743A (nl) Werkwijze voor het bereiden van pyridylalkyl- amidinen, werkwijze voor het bereiden van far- maceutische preparaten met antihyperglycaemische werking alsmede hierbij verkregen gevormde pre- paraten.
DE68926813D1 (de) Von gemeinsamen sequenzen von antigenen und antiidiotypischen antikörpern oder von antikörpern mit spezifizität für die zellulären rezeptoren der antigene abgeleitete immunogene und biologisch aktive peptide
GB916455A (en) Non-toxic antigens and process for producing same
GB1437006A (en) Antidistemper and anti-hepatitis vaccines
FI972658L (fi) Menetelmä rokotteen valmistamiseksi siipikarjan tarttuvaa bursaalitautia vastaan
JPS5344620A (en) Recovering of immobilized vaccine and specific antigen

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19920815